Methoxetamine: From drug of abuse to rapid-acting antidepressant

被引:28
|
作者
Coppola, M. [1 ]
Mondola, R. [2 ]
机构
[1] ASL CN2, Dept Addict, I-12051 Alba, CN, Italy
[2] ASL CN1, Dept Mental Hlth, I-12037 Saluzzo, CN, Italy
关键词
MAJOR DEPRESSIVE DISORDER; D-ASPARTATE ANTAGONIST; RESISTANT BIPOLAR DEPRESSION; STAR-ASTERISK-D; ELECTROCONVULSIVE-THERAPY; ALCOHOL DEPENDENCE; SIGMA-RECEPTORS; CHRM2; GENE; RAT-BRAIN; KETAMINE;
D O I
10.1016/j.mehy.2012.07.002
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Methoxetamine is a dissociative anaesthetic showing pharmacodynamic similarities with its analogue ketamine, a medication with demonstrated rapid-acting antidepressant effects. Like ketamine and other arylcyclohexylamine compounds, methoxetamine is thought to be both a noncompetitive NMDA receptor antagonist and a dopamine reuptake inhibitor. Furthermore, it acts as an agonist at dopamine D2, serotonin 5HT2, muscarinic cholinergic, sigma-1, opioid mu and k receptors. The hypothesis is that methoxetamine can produce rapid antidepressant effects in patients with resistant and non-resistant unipolar and bipolar depression. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:504 / 507
页数:4
相关论文
共 50 条
  • [1] A New Rapid-Acting Antidepressant
    Krystal, John H.
    Charney, Dennis S.
    Duman, Ronald S.
    CELL, 2020, 181 (01) : 7 - 7
  • [2] Dextromethorphan as a potential rapid-acting antidepressant
    Lauterbach, Edward C.
    MEDICAL HYPOTHESES, 2011, 76 (05) : 717 - 719
  • [3] Targeting metabotropic glutamate receptors for rapid-acting antidepressant drug discovery
    Musazzi, Laura
    EXPERT OPINION ON DRUG DISCOVERY, 2021, 16 (02) : 147 - 157
  • [4] Rapid-acting antidepressant strategies: mechanisms of action
    Bunney, Blynn G.
    Bunney, William E.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 (05): : 695 - 713
  • [6] L-Acetylcarnitine: A Mechanistically Distinctive and Potentially Rapid-Acting Antidepressant Drug
    Chiechio, Santina
    Canonico, Pier Luigi
    Grilli, Mariagrazia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (01)
  • [7] KETAMINE: FROM PROBE OF CORTICAL DYSFUNCTION IN SCHIZOPHRENIA TO RAPID-ACTING ANTIDEPRESSANT
    Krystal, John H.
    BEHAVIOURAL PHARMACOLOGY, 2013, 24 : E1 - E1
  • [8] Concerns about dextromethorphan as a potential rapid-acting antidepressant
    Zhou, Zhiqiang
    Wu, Jing
    Yang, Chun
    MEDICAL HYPOTHESES, 2011, 77 (02) : 309 - 310
  • [9] Risks Associated with Misuse of Ketamine as a Rapid-Acting Antidepressant
    Zhu, Weili
    Ding, Zengbo
    Zhang, Yinan
    Shi, Jie
    Hashimoto, Kenji
    Lu, Lin
    NEUROSCIENCE BULLETIN, 2016, 32 (06) : 557 - 564
  • [10] Risks Associated with Misuse of Ketamine as a Rapid-Acting Antidepressant
    Weili Zhu
    Zengbo Ding
    Yinan Zhang
    Jie Shi
    Kenji Hashimoto
    Lin Lu
    Neuroscience Bulletin, 2016, 32 (06) : 557 - 564